InvestorsHub Logo
Followers 2
Posts 2964
Boards Moderated 0
Alias Born 06/23/2017

Re: None

Thursday, 04/18/2019 7:36:02 PM

Thursday, April 18, 2019 7:36:02 PM

Post# of 44784
Don’t know how some are coming up with $29 mil from the raise because it isn’t. $20 mil. Minus costs. No wonder financials are avoided at all cost. Unless you’re thinking below price warrants are being exercised. Maybe the goon squads doing that. Misrepresentation is all they have ever put out. Go management!!! Saying $29 mil is something management would say. LMBO.

Here’s an interesting tidbit I found from the prospectus supplement.

“Assuming we receive a contract from the U.S. government, we expect to initiate an ARS pivotal trial in the second half of 2019”

Are they trying to play hardball with the government? What kind of a contract are they talking about? They should have just let them do the trial and receive nothing in return. At least it would have been done long ago, with results. At least it explains the 2 year delay since dosing trial was completed. These are two bit clowns making it up as they go. Epic fail so far. How they have their jobs astonishes me. But their buddies on the board make sure they stay, along with the millions of votes shares.